Stryker announces Annual Meeting of Shareholders
Get Alerts SYK Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.1%
Revenue Growth %: +10.4%
Join SI Premium – FREE
Portage, Michigan, March 26, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows:
Thursday, May 9, 2024 – 9:30 a.m. Eastern Time
The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker Corporation Annual Meeting" when greeted by the operator.
A recording of the annual meeting will also be available from 10:30 a.m., Eastern Time, on Friday, May 10, 2024 at www.virtualshareholdermeeting.com/SYK2024 until the definitive proxy statement for our 2025 Annual Meeting of Shareholders is filed with the United States Securities and Exchange Commission.
About Stryker
Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or [email protected]
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HAIRCUTS FOR HEROES EVENT PROVIDES FREE HAIRCUTS FOR VETERANS, FIRST RESPONDERS, AND ACTIVE-DUTY SERVICE MEMBERS
- Why Many Companies Are Reconsidering Coverage for GLP-1 Drugs
- Brookfield Office Properties Announces Reset Dividend Rates and Conversion Privileges on Its Class AAA Series R Preference Shares
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share